SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The Company's technology can also be applied to other mammalian species.
BörsenkürzelSNES
Name des UnternehmensSenestech Inc
IPO-datumDec 08, 2016
CEOMr. Joel L. Fruendt
Anzahl der mitarbeiter23
WertpapierartOrdinary Share
GeschäftsjahresendeDec 08
Addresse777 W. Pinnacle Peak Road
StadtPHOENIX
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl85027
Telefon19287794143
Websitehttps://senestech.com/
BörsenkürzelSNES
IPO-datumDec 08, 2016
CEOMr. Joel L. Fruendt
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten